About Wanbangde Pharmaceutical Holding Group Company

The company's main business is pharmaceutical manufacturing and the health industry, which mainly focuses on medical devices. It is a listed pharmaceutical manufacturing company in Shenzhen. The company is mainly engaged in R&D, production and sales of modern traditional Chinese medicines, chemical raw materials and chemical preparations, high-end medical device development, medical equipment services and hospital engineering services. The company's main products: huperzine, controlled release tablets, chlorpromazine hydrochloride tablets, cimetidine tablets, cefaclor granules, norfloxacin tablets, sulpiride tablets, lidocaine hydrochloride injections, bromhexine hydrochloride solution for inhalation, WP107, WP103, WP203A, lipoic acid, alanyl glutamine, SM13, medical equipment and hospital engineering integration services, disposable sterile medical polymer devices, orthopedic instruments. Company honors include China's top 20 construction profile enterprises, Zhejiang Province's top 100 fastest growing enterprises, Zhejiang Province's leading demonstration enterprise for transformation and upgrading, Zhejiang Province's clean production stage achievement enterprises, China's top 500 private enterprise manufacturing enterprises, “2022 China's Top 100 Chinese Medicine Enterprises”, “2023-2023 Outstanding Chinese Medicine Brand Enterprise”, and the company's bromhexine hydrochloride tablets are included in the “2023 Comprehensive Statistical Ranking of Chinese OTC Pharmaceutical Products - 2nd Place in Chemical Drugs and Cough-Relieving Phlegm Products”, Huixerine A and Formulation Development and Industrialized applications have obtained honors such as the “Science and Technology Achievement Registration Certificate”.